Dr. Ethan D. Miller, MD

Dr. Miller practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Miller's NPI, 1629281704, was assigned on May 7, 2007. Dr. Miller graduated from Baylor College Of Medicine in 2004. Dr. Miller's Texas license number on file is N7463.

Dr. Miller's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Miller's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Miller practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Miller's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Miller is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Miller's licenses on file in 10 states: Texas, Florida, Georgia, Mississippi, Oklahoma, Alabama, Arizona, Louisiana, Tennessee and Washington.

Dmand AI lists cirrhosis of the liver, colonoscopy, fatty liver, gastrointestinal bleeding and upper GI endoscopy among the conditions Dr. Miller treats.

CMS data shows 317 Medicare services from Dr. Miller across 10 procedure codes in 2024, for 285 Medicare patients. Medicare paid $29,532 for them.

CMS counts 285 Medicare patients who saw Dr. Miller in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Miller's median patient age at 70, with 51% women.

In 2024, Dr. Miller wrote 45 Medicare Part D claims for 15 patients. 80% of them were for generic drugs. CMS names the drug for 20 of them, across 1 drug with 11 or more claims each, at $1,766 in total drug cost. In 2023, CMS named 28 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Miller for performance year 2024, reported as part of a group. Dr. Miller accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Miller as offering telehealth. CMS counts 65 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Miller, more than 68% of the clinicians it reports for that procedure.

Dmand AI links 29 papers to Dr. Miller, published from 2010 to 2023. 2018 was the busiest year, with 4. The most frequent topics are Liver Neoplasms, Antiviral Agents and Carcinoma, Hepatocellular. Dr. Miller has published most often in Am J Gastroenterol. Dr. Miller's most frequent co-authors are Naga Prasad Chalasani, MD, Gottumukkala S. Raju, MD and Selvi Thirumurthi, MD.

CMS Open Payments shows 15 general payments to Dr. Miller from 6 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 85% of the total. Bristol-Myers Squibb Company paid the most, $3,937.

Dr. Miller graduated from Baylor College Of Medicine in 2004.

Dr. Miller is in network with 4 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.